|
EPIGENETIC GENE SILENCING
|
|||
| Rohinton
Kamakaka, Ph.D., Head, Unit on Chromatin
and Transcription Namrita Dhillon, Ph.D., Research Fellow Sunil Gangadharan, Ph.D., Postdoctoral Fellow Devyani Haldar, Ph.D., Postdoctoral Fellow Masaya Oki, Ph.D., Postdoctoral Fellow Lourdes Valenzuela, Ph.D., Postdoctoral Fellow |
![]() |
||
|
Research in this laboratory is devoted to understanding the mechanisms by which entire regions of the genome are rendered inaccessible to transcription and recombination. The laboratory uses genetic analysis, coupled with biochemical fractionation and reconstitution experiments, to explore the issues of genome accessibility. Silencing of genomic domains requires a complex series of interactions between inactivation centers called silencers and numerous repressor proteins. The silencers recruit repressor protein complexes composed of the Sir proteins, which then interact with histones in nucleosomes to form a chromatin domain, a domain that is both inaccessible and inert to various cellular processes. We are currently focusing on these proteins and their interactions with the histones to understand, in molecular detail, the mechanism by which silencing is effected. Histone Variants and Cell Cycle Progression The role of histone variants in gene expression is poorly understood. To understand the function of Sir1 in silencing in S. cerevisiae, we generated yeast cells with mutations in this protein that were unable to silence even after Sir1 was recruited to the silencer, presumably owing to a weakened interaction between Sir1p and the other proteins involved in silencing. Overproduction of the histone variant Htz1p in the sir1 mutant could compensate for its weakened interaction (Dhillon and Kamakaka, 2000). We are currently interested in understanding the many roles of this protein in the cell. Classical molecular genetic and biochemical experiments are under way to identify the domains of Htz1 involved in cell cycle progression, determine the response to drugs such as hydroxyurea and benomyl, and identify the proteins that interact with Htz1 to function in the cell. Identification and Characterization of Sir Protein
Complexes Involved in Silencing We will employ reverse genetics to determine the function of any novel
polypeptides associated with these complexes. We will also perform experiments
to analyze the nature of the interactions between these Sir protein complexes
and histones in nucleosomes. This analysis will involve binding studies
with purified Sir complexes and positioned nucleosomes in arrays, followed
by DNaseI foot-printing and protein-protein cross-linking and sedimentation
analyses. Long-term goals call for studies on the regulation of these
enzymes within the cell and in vitro studies
aimed toward the eventual development of specific inhibitors for these
enzymes that may have therapeutic value. Role of Nuclear Architecture in Silencing Analysis of Sir2p in Other Eukaryotes |
|||
|
SELECTED PUBLICATIONS
COLLABORATOR Takashi Ito, Ph.D., Kanazawa University, Kanazawa, Japan |
|||